本页面由Tiger Trade Technology Pte. Ltd.提供服务

ProQR Therapeutics N.V.

2.09
-0.0300-1.42%
盘后2.090.00000.00%19:20 EST
成交量:68.71万
成交额:141.69万
市值:2.20亿
市盈率:-4.33
高:2.12
开:2.11
低:2.01
收:2.12
52周最高:3.71
52周最低:1.07
股本:1.05亿
流通股本:6,753.07万
量比:1.14
换手率:1.02%
股息:- -
股息率:- -
每股收益(TTM):-0.4823
每股收益(LYR):-0.3339
净资产收益率:-103.76%
总资产收益率:-24.02%
市净率:3.31
市盈率(LYR):-6.26

数据加载中...

2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/03

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/29

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/28

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/12/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/08

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/10/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/28

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/08/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]